Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Research article

Linear echoendoscope-guided ERCP for the diagnosis of occult common bile duct stones

Authors: Hoi-Hung Chan, E-Ming Wang, Meng-Shun Sun, Ping-I Hsu, Wei-Lun Tsai, Tzung-Jiun Tsai, Kai-Ming Wang, Wen-Chi Chen, Huay-Min Wang, Huei-Lung Liang, Kwok-Hung Lai, William Robert Brugge

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Less than 67% of patients with intermediate risk for common bile duct (CBD) stones require therapeutic intervention. It is important to have an accurate, safe, and reliable method for the definitive diagnosis of CBD stones before initiating therapeutic endoscopic retrograde cholangiopancreatography (ERCP). Few publications detail the diagnostic efficacy of linear echoendoscopy (EUS) for CBD stones.

Methods

30 patients with biliary colic, pancreatitis, unexplained derangement of liver function tests, and/or dilated CBD without an identifiable cause were enrolled in the study. When a CBD stone was disclosed by linear EUS, ERCP with stone extraction was performed. Patients who failed ERCP were referred for surgical intervention. If no stone was found by EUS, ERCP would not be performed and patients were followed-up for possible biliary symptoms for up to three months.

Results

The major reason for enrollment was acute pancreatitis. The mean predicted risk for CBD stones was 47% (28–61). Of the 12 patients who were positive for CBD stones by EUS, nine had successful ERCP, one failed ERCP (later treated successfully by surgical intervention) and two were false-positive cases. No procedure-related adverse events were noted. For those 18 patients without evidence of CBD stones by EUS, no false-negative case was noted during the three-month follow-up period. Linear EUS had sensitivity, specificity, positive and negative predicted values for the detection of CBD stones of 1, 0.9, 0.8 and 1, respectively.

Conclusion

Linear EUS is safe and efficacious for the diagnosis of occult CBD stones in patients with intermediate risk for the disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Institutes of Health: National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg. 1993, 165 (4): 390-398.CrossRef National Institutes of Health: National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg. 1993, 165 (4): 390-398.CrossRef
2.
go back to reference Barkun AN, Barkun JS, Fried GM, Ghitulescu G, Steinmetz O, Pham C, Meakins JL, Goresky CA: Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. McGill Gallstone Treatment Group. Ann Surg. 1994, 220 (1): 32-39. 10.1097/00000658-199407000-00006.CrossRefPubMedPubMedCentral Barkun AN, Barkun JS, Fried GM, Ghitulescu G, Steinmetz O, Pham C, Meakins JL, Goresky CA: Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. McGill Gallstone Treatment Group. Ann Surg. 1994, 220 (1): 32-39. 10.1097/00000658-199407000-00006.CrossRefPubMedPubMedCentral
3.
go back to reference Tseng CW, Chen CC, Chen TS, Chang FY, Lin HC, Lee SD: Can computed tomography with coronal reconstruction improve the diagnosis of choledocholithiasis?. J Gastroenterol Hepatol. 2008, 23 (10): 1586-1589. 10.1111/j.1440-1746.2008.05547.x.CrossRefPubMed Tseng CW, Chen CC, Chen TS, Chang FY, Lin HC, Lee SD: Can computed tomography with coronal reconstruction improve the diagnosis of choledocholithiasis?. J Gastroenterol Hepatol. 2008, 23 (10): 1586-1589. 10.1111/j.1440-1746.2008.05547.x.CrossRefPubMed
4.
go back to reference Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998, 48 (1): 1-10. 10.1016/S0016-5107(98)70121-X.CrossRefPubMed Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998, 48 (1): 1-10. 10.1016/S0016-5107(98)70121-X.CrossRefPubMed
5.
go back to reference Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ: Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996, 335 (13): 909-918. 10.1056/NEJM199609263351301.CrossRefPubMed Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ: Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996, 335 (13): 909-918. 10.1056/NEJM199609263351301.CrossRefPubMed
6.
go back to reference Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, Minoli G, Crosta C, Comin U, Fertitta A: Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001, 96 (2): 417-423. 10.1111/j.1572-0241.2001.03594.x.CrossRefPubMed Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, Minoli G, Crosta C, Comin U, Fertitta A: Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001, 96 (2): 417-423. 10.1111/j.1572-0241.2001.03594.x.CrossRefPubMed
7.
go back to reference Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N: Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991, 37 (3): 383-393. 10.1016/S0016-5107(91)70740-2.CrossRefPubMed Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N: Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991, 37 (3): 383-393. 10.1016/S0016-5107(91)70740-2.CrossRefPubMed
8.
go back to reference Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL: Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006, 101 (1): 139-147. 10.1111/j.1572-0241.2006.00380.x.CrossRefPubMed Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL: Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006, 101 (1): 139-147. 10.1111/j.1572-0241.2006.00380.x.CrossRefPubMed
9.
go back to reference Karakan T, Cindoruk M, Alagozlu H, Ergun M, Dumlu S, Unal S: EUS versus endoscopic retrograde cholangiography for patients with intermediate probability of bile duct stones: a prospective randomized trial. Gastrointest Endosc. 2009, 69 (2): 244-252. 10.1016/j.gie.2008.05.023.CrossRefPubMed Karakan T, Cindoruk M, Alagozlu H, Ergun M, Dumlu S, Unal S: EUS versus endoscopic retrograde cholangiography for patients with intermediate probability of bile duct stones: a prospective randomized trial. Gastrointest Endosc. 2009, 69 (2): 244-252. 10.1016/j.gie.2008.05.023.CrossRefPubMed
10.
go back to reference Polkowski M, Regula J, Tilszer A, Butruk E: Endoscopic ultrasound versus endoscopic retrograde cholangiography for patients with intermediate probability of bile duct stones: a randomized trial comparing two management strategies. Endoscopy. 2007, 39 (4): 296-303. 10.1055/s-2007-966264.CrossRefPubMed Polkowski M, Regula J, Tilszer A, Butruk E: Endoscopic ultrasound versus endoscopic retrograde cholangiography for patients with intermediate probability of bile duct stones: a randomized trial comparing two management strategies. Endoscopy. 2007, 39 (4): 296-303. 10.1055/s-2007-966264.CrossRefPubMed
11.
go back to reference Verma D, Kapadia A, Eisen GM, Adler DG: EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc. 2006, 64 (2): 248-254. 10.1016/j.gie.2005.12.038.CrossRefPubMed Verma D, Kapadia A, Eisen GM, Adler DG: EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc. 2006, 64 (2): 248-254. 10.1016/j.gie.2005.12.038.CrossRefPubMed
12.
go back to reference Kondo S, Isayama H, Akahane M, Toda N, Sasahira N, Nakai Y, Yamamoto N, Hirano K, Komatsu Y, Tada M: Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography. Eur J Radiol. 2005, 54 (2): 271-275. 10.1016/j.ejrad.2004.07.007.CrossRefPubMed Kondo S, Isayama H, Akahane M, Toda N, Sasahira N, Nakai Y, Yamamoto N, Hirano K, Komatsu Y, Tada M: Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography. Eur J Radiol. 2005, 54 (2): 271-275. 10.1016/j.ejrad.2004.07.007.CrossRefPubMed
13.
go back to reference Tandon M, Topazian M: Endoscopic ultrasound in idiopathic acute pancreatitis. Am J Gastroenterol. 2001, 96 (3): 705-709. 10.1111/j.1572-0241.2001.03609.x.CrossRefPubMed Tandon M, Topazian M: Endoscopic ultrasound in idiopathic acute pancreatitis. Am J Gastroenterol. 2001, 96 (3): 705-709. 10.1111/j.1572-0241.2001.03609.x.CrossRefPubMed
14.
go back to reference Kohut M, Nowakowska-Dulawa E, Marek T, Kaczor R, Nowak A: Accuracy of linear endoscopic ultrasonography in the evaluation of patients with suspected common bile duct stones. Endoscopy. 2002, 34 (4): 299-303. 10.1055/s-2002-23641.CrossRefPubMed Kohut M, Nowakowska-Dulawa E, Marek T, Kaczor R, Nowak A: Accuracy of linear endoscopic ultrasonography in the evaluation of patients with suspected common bile duct stones. Endoscopy. 2002, 34 (4): 299-303. 10.1055/s-2002-23641.CrossRefPubMed
15.
go back to reference Maple JT, Ikenberry SO, Anderson MA, Appalaneni V, Decker GA, Early D, Evans JA, Fanelli RD, Fisher D, Fisher L: The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc. 2011, 74 (4): 731-744. 10.1016/j.gie.2011.04.012.CrossRefPubMed Maple JT, Ikenberry SO, Anderson MA, Appalaneni V, Decker GA, Early D, Evans JA, Fanelli RD, Fisher D, Fisher L: The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc. 2011, 74 (4): 731-744. 10.1016/j.gie.2011.04.012.CrossRefPubMed
16.
go back to reference Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A, Petersen BT, Petrini JL: A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010, 71 (3): 446-454. 10.1016/j.gie.2009.10.027.CrossRefPubMed Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A, Petersen BT, Petrini JL: A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010, 71 (3): 446-454. 10.1016/j.gie.2009.10.027.CrossRefPubMed
17.
go back to reference Kohut M, Nowak A, Nowakowska-Dulawa E, Marek T, Kaczor R: Endosonography with linear array instead of endoscopic retrograde cholangiography as the diagnostic tool in patients with moderate suspicion of common bile duct stones. World J Gastroenterology. 2003, 9 (3): 612-614.CrossRef Kohut M, Nowak A, Nowakowska-Dulawa E, Marek T, Kaczor R: Endosonography with linear array instead of endoscopic retrograde cholangiography as the diagnostic tool in patients with moderate suspicion of common bile duct stones. World J Gastroenterology. 2003, 9 (3): 612-614.CrossRef
Metadata
Title
Linear echoendoscope-guided ERCP for the diagnosis of occult common bile duct stones
Authors
Hoi-Hung Chan
E-Ming Wang
Meng-Shun Sun
Ping-I Hsu
Wei-Lun Tsai
Tzung-Jiun Tsai
Kai-Ming Wang
Wen-Chi Chen
Huay-Min Wang
Huei-Lung Liang
Kwok-Hung Lai
William Robert Brugge
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-44

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine